-transparent.png){kind=logo}
Twenty-five patients with disseminated gastrointestinal malignancies were treated in a phase I study with a combination of ftorafur and mitomycin C or florafur and methyl-CCNU. Most patients had been heavily treated previously. Gastrointestinal, central nervous system, and marrow toxicity were manageable. Tumor regression was noted in five of 25 patients. A large-scale phase II study in untreated patients with gastrointestinal malignancies appears indicated with a combination of these agents.
Related Publications
T Buroker, and
L Baker, and
J Correa, and
L A Schwartz, and
V K Vailtkevicius
September 1979,
Cancer,
T Buroker, and
L Baker, and
J Correa, and
L A Schwartz, and
V K Vailtkevicius
January 1981,
Oncology,
T Buroker, and
L Baker, and
J Correa, and
L A Schwartz, and
V K Vailtkevicius
January 1995,
Journal of cancer research and clinical oncology,
T Buroker, and
L Baker, and
J Correa, and
L A Schwartz, and
V K Vailtkevicius
October 1979,
Cancer,
T Buroker, and
L Baker, and
J Correa, and
L A Schwartz, and
V K Vailtkevicius
August 1977,
Cancer treatment reports,
T Buroker, and
L Baker, and
J Correa, and
L A Schwartz, and
V K Vailtkevicius
January 1981,
Recent results in cancer research. Fortschritte der Krebsforschung. Progres dans les recherches sur le cancer,
T Buroker, and
L Baker, and
J Correa, and
L A Schwartz, and
V K Vailtkevicius
August 2004,
British journal of cancer,
T Buroker, and
L Baker, and
J Correa, and
L A Schwartz, and
V K Vailtkevicius
January 1981,
Cancer clinical trials,
T Buroker, and
L Baker, and
J Correa, and
L A Schwartz, and
V K Vailtkevicius
February 1983,
Nihon Gan Chiryo Gakkai shi,
T Buroker, and
L Baker, and
J Correa, and
L A Schwartz, and
V K Vailtkevicius
January 1981,
Cancer chemotherapy and pharmacology,
